The North America Protein Engineering Market would witness market growth of 15.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$2.14 billion by 2031. The Canada market is experiencing a CAGR of 18.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 17.1% during (2024 - 2031).
The market has become a highly dynamic and swiftly developing sector in the biotechnology industry, influencing numerous fields such as agriculture, industrial biotechnology, healthcare, and environmental science. This transformative field leverages the principles of molecular biology, genetic engineering, and bioinformatics to design and construct novel proteins or modify existing ones with enhanced or entirely new functions.
Protein engineering involves modifying protein structures to improve their properties or endow them with new capabilities. Proteins, the fundamental building blocks of life, perform myriad functions within biological systems, from catalyzing metabolic reactions as enzymes to serving as structural components and signaling molecules. The capacity to precisely engineer these molecules presents an abundance of prospects for the advancement of novel therapeutics, industrial enzymes, biosensors, and additional applications.
In Mexico, the demand for this engineering is driven by factors such as a growing pharmaceutical industry and increasing investment in research and development. According to the Mexican Association of Pharmaceutical Research Industries (AMIIF), the pharmaceutical sector in Mexico has been growing steadily. This growth is partly fueled by increasing investment in research and development, which drives demand for engineering technologies and expertise. Consequently, these factors create significant market opportunities for engineering technologies and products, leading to continued growth and innovation.
Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$2.14 billion by 2031. The Canada market is experiencing a CAGR of 18.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 17.1% during (2024 - 2031).
The market has become a highly dynamic and swiftly developing sector in the biotechnology industry, influencing numerous fields such as agriculture, industrial biotechnology, healthcare, and environmental science. This transformative field leverages the principles of molecular biology, genetic engineering, and bioinformatics to design and construct novel proteins or modify existing ones with enhanced or entirely new functions.
Protein engineering involves modifying protein structures to improve their properties or endow them with new capabilities. Proteins, the fundamental building blocks of life, perform myriad functions within biological systems, from catalyzing metabolic reactions as enzymes to serving as structural components and signaling molecules. The capacity to precisely engineer these molecules presents an abundance of prospects for the advancement of novel therapeutics, industrial enzymes, biosensors, and additional applications.
In Mexico, the demand for this engineering is driven by factors such as a growing pharmaceutical industry and increasing investment in research and development. According to the Mexican Association of Pharmaceutical Research Industries (AMIIF), the pharmaceutical sector in Mexico has been growing steadily. This growth is partly fueled by increasing investment in research and development, which drives demand for engineering technologies and expertise. Consequently, these factors create significant market opportunities for engineering technologies and products, leading to continued growth and innovation.
Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Waters Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Danaher Corporation
- Genscript Biotech Corporation
- Amgen, Inc.
- Promega Corporation
Market Report Segmentation
By Product- Instruments
- Reagents
- Software & Services
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Rational Protein Design
- Hybrid Approach
- Directed Evolution
- De Novo Protein Design
- Others
- Monoclonal Antibodies
- Insulin
- Vaccines
- Growth Factors
- Interferon
- Colony Stimulating Factors
- Coagulation Factors
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Protein Engineering Market by Product
Chapter 5. North America Protein Engineering Market by End-use
Chapter 6. North America Protein Engineering Market by Technology
Chapter 7. North America Protein Engineering Market by Protein Type
Chapter 8. North America Protein Engineering Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Waters Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Danaher Corporation
- Genscript Biotech Corporation
- Amgen, Inc.
- Promega Corporation
Methodology
LOADING...
